A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 973
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ST
Long Form : stent thrombosis
No. Year Title Co-occurring Abbreviation
2021 "Burying" covered coronary stents under drug-eluting stents: A novel approach to ensure long-term stent patency. CS, DES, FU, IQR, ISR
2021 3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation. DES, IVUS, TVF
2021 A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients. EES, LLL, MI, PES, RCTs, SES, TLR, TVR
2021 A Prospective, observational, Italian multi-center registry of self-aPposing® cOronary Stents in patients presenting with ST-segment Elevation Myocardial InfarcTION: The iPOSITION registry. CD, PPCI, STEMI, TLF, TLR, TV-MI
2021 A study of unprotected left main intervention in the ACS population 2013-2018. EDS, MI, TLR
2021 Analysis of risk factors for early stent thrombosis in the Chinese population: A multicenter restrospective study. AUC, EST, OR, PCI, SYNTAX
2021 Aspiration thrombectomy in ST-Elevation myocardial infarction: Further insights from a network meta-analysis of randomized trials. AT, C-PCI, LVEF, MACE, MBG, McT, MI, OR, PCI, STEMI, STR, TVR
2021 Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model. BARC, MI, PCI
2021 Association of pre-percutaneous coronary flow grade and clinical outcomes in patients with non-ST-segment elevation myocardial infarction: Data from the Korea Acute Myocardial Infarction Registry. CI, HR, NSTEMI, pre-PCI, PSM, TIMI
10  2021 Bioresorbable polymer and durable polymer metallic stents in coronary artery disease: a meta-analysis. BPS, DPS, MI, PCI, TVMI, TVR
11  2021 Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in high-bleeding-risk patients with acute coronary syndrome in contemporary practice. ACS, GPIs, MACEs, NACEs, PCI, TVR, UFH
12  2021 Cancer Patients Have a Higher Risk of Thrombotic and Ischemic Events After Percutaneous Coronary Intervention. MI, PCI
13  2021 Clinical Outcomes of Self-Made Polyurethane-Covered Stent Implantation for the Treatment of Coronary Artery Perforations. CAP, MACE, MI, PCI, PU-CS, TLR
14  2021 Clinical outcomes of ultrathin strut biodegradable polymer-coated everolimus-eluting stent in patients with coronary artery disease. CAD, CTRI, DES, EES, ID-TLR, MACE
15  2021 Comparison of First- and Second-Generation Drug-Eluting Stents in Patients with ST-Segment Elevation Myocardial Infarction Based on Pre-Percutaneous Coronary Intervention Thrombolysis in Myocardial Infarction Flow Grade. aHR, DES, MACEs, PCI, re-MI, STEMI, TIMI
16  2021 Coronary Stenting: Reflections on a 35-Year Journey. ACS, AMI, PCI, POBA
17  2021 Diabetes mellitus is independently associated with early stent thrombosis in patients undergoing drug eluting stent implantation: Analysis from the Victorian cardiac outcomes registry. DES, DM, MACE, PCI
18  2021 Drug-Coated Balloon versus Drug-Eluting Stent in Patients with Small-Vessel Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials. DCB, DES, ISR, MACE, MI, PCI, RCTs, SVD, TLR, TVR
19  2021 Drug-eluting stent thrombosis: current and future perspectives. DES
20  2021 Dual Versus Triple Therapy in Patients with Acute Coronary Syndrome and an Anticoagulation Indication: A Systematic Review with Meta-Analysis and Trial-Sequential Analysis. ACS, CI, DT, MACE, MI, RR
21  2021 Effects of clopidogrel, prasugrel and ticagrelor on prevention of stent thrombosis in patients underwent percutaneous coronary intervention: A network meta-analysis. CIs, ORs, PCI, RCTs
22  2021 Effects of electret coating technology on coronary stent thrombogenicity. BMS, e-DES
23  2021 Effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients. AMI, POCOs, re-MI
24  2021 Efficacy and Safety of Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation: A Systematic Review and Network Meta-Analysis. DAPTs, DESs, MI, NACE, PCI, RCTs
25  2021 Everolimus-eluting bioresorbable coronary scaffold in Asian patients: A 2-year follow-up. BVS, CAD, DES
26  2021 Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry. ACS, CAD, MI, NACE, OHCA, PCI, TVR
27  2021 Final 5-Year Results in Randomized Japanese Patients Implanted With a Thin-Strut, Bioabsorbable, Polymer-Coated, Everolimus-Eluting SYNERGY Stent (From the EVOLVE II Study). TLF
28  2021 Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial. ACS, DAPT, DES, TVR
29  2021 Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial. ACS, DAPT, PCI, TVR
30  2021 Incidence and Predictors of Stent Thrombosis in Patients Treated with Stents for Coronary Bifurcation Narrowing (From the BIFURCAT Registry). DAPT, FKB
31  2021 Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials. CD-TLR, CI, DES, MI, RCTs, RR, TLF
32  2021 Mean platelet volume/platelet count ratio as a predictor of stent thrombosis in patients with ST-segment-elevation myocardial infarction. MPV, PC, PPCI, STEMI
33  2021 Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y12 Inhibitor Thereafter. DAPT, DES, RCT, SAPT
34  2021 Nine-month angiographic and 2-year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus-eluting COMBO dual-therapy stent versus a polymer-free sirolimus-eluting stent in Chinese patients. EPC, LLL, POCE, TLF
35  2021 One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration. ACS, EPC, NSTEMI, STEMI, TLF, UA
36  2021 Optimal Stent Design for High Bleeding Risk Patients: Evidence From a Network Meta-Analysis. BMS, DAPT, DES, HBR, MACE, MI, PB, PF, RCTs, TLR, TVR
37  2021 Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report. DES, HR, ISR, MI, PCI, SCAAR
38  2021 Outcomes of Drug-Eluting Stent Thrombosis After Treatment for Acute Versus Chronic Coronary Syndrome. ACS, CCS
39  2021 Polymer-free biolimus-eluting stents or polymer-based zotarolimus-eluting stents for coronary bifurcation lesions. MACE, MI, PCI, PF-BES, TLR, ZES
40  2021 Post-Stent Optical Coherence Tomography Findings at Index Percutaneous Coronary Intervention - Characteristics Related to Subsequent Stent Thrombosis. AMI, IP, OCT, PCI, ST group
41  2021 Procedural and 1-year outcomes following large vessel coronary artery perforation treated by covered stents implantation: Multicentre CRACK registry. CAPs, CSs, MACEs, MI, TLR
42  2021 Risk Factors and Outcomes of Recurrent Drug-Eluting Stent Thrombosis: Insights From the REAL-ST Registry. DES, HR, RST
43  2021 Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational study. CIs, CV, DES, HRs, ISR, MACE, PCI
44  2021 Sex difference after acute myocardial infarction patients with a history of current smoking and long-term clinical outcomes: Results of KAMIR Registry. aHR, AMI, CI, DESs, MACEs, re-MI
45  2021 Stent strut streamlining and thickness reduction promote endothelialization. CA, RT
46  2021 Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES. ACS, CI, HPR, HR, HR, MI, PCI
47  2021 Targeting "diabetic" coronary stenosis merging the properties of sirolimus coated balloon with sirolimus eluting stent. DM, MACE, MI, TLR, TVR
48  2021 Ten-year outcomes of early generation sirolimus- versus paclitaxel-eluting stents in patients with left main coronary artery disease. CI, DES, HR, IPTW, LMCA, MI, PES, SES, TVR
49  2021 The relationship between coronary stent strut thickness and the incidences of clinical outcomes after drug-eluting stent implantation: A systematic review and meta-regression analysis. DESs, PMI, RCTs, RR, TLR
50  2021 Ticagrelor effectively inhibits platelet aggregation in comatose survivors of cardiac arrest undergoing primary percutaneous coronary intervention treated with mild therapeutic hypothermia. MTH, OHCA, PCI
51  2021 Two-Year Clinical Outcomes of Biodegradable Polymer vs. Durable Polymer Drug-Eluting Stent Implantation in Patients With End-Stage Renal Disease on Dialysis. CD, ESRD, MACE, MI, PCI, TLR, TVR
52  2021 Two-year safety and efficacy of Indigenous Abluminus Sirolimus Eluting Stent. Does it differ amongst diabetics? - Data from en-ABLe- REGISTRY. TLR, TV-MI, TVR
53  2021 Ultrathin (60 μm), ultralong (≥40 mm) sirolimus-eluting stent: study of clinical and safety profiles among real-world patients. DES, LDZ-link, MI, POCE, SES, TLF, TLR
54  2021 Uncommon but imperative cause of repeated acute stent thrombosis: Kounis syndrome type III. ---
55  2020 1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration. PCI, TLF, TLR, TV-MI
56  2020 A case report of Kounis syndrome presenting with a rash, very late stent thrombosis and coronary evaginations. DESs, KS, SESs
57  2020 Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis. ACS, CI, DAT, ICH, OAT, PCI, RCTs, TAT, TIMI, VKA
58  2020 Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis. AF, CAD, DAPT, OAC, PCI, TAT
59  2020 Are we curing one evil with another? A translational approach targeting the role of neoatherosclerosis in late stent failure. ---
60  2020 Biodegradable polymer-coated versus durable polymer-coated sirolimus-eluting stents: the final 5-year outcomes of the I-LOVE-IT 2 trial. BP, CI, DAPT, DP, HR, MI, SES, TLF
61  2020 Case report: intravascular ultrasound sonography-guided re-entry technique in crushed stent. IVUS, STEMI
62  2020 Clinical impact of calcified nodule in patients with heavily calcified lesions requiring rotational atherectomy. CD-TLR, CI, CN, DES, HR, MACE, RA
63  2020 Clinical Outcomes After Implantation of Polyurethane-Covered Cobalt-Chromium Stents: Insights from the Papyrus-Spain Registry. CAA, CAP, CS, MACE
64  2020 Clinical outcomes after percutaneous coronary intervention for early versus late and very late stent thrombosis: a systematic review and meta-analysis. EST, LST, PCI, rST, TVR/TLR, VLST
65  2020 Clinical outcomes following polymer-free sirolimus-eluting stent implantations in unselected patients: A descriptive subgroup analysis in patients with renal impairment. NRF
66  2020 Clinical outcomes following ST-elevation myocardial infarction secondary to stent thrombosis treated by percutaneous coronary intervention. PCI, STEMI
67  2020 Clinical safety and efficacy of World's thinnest (50 mum), very long (>40 mm) Everolimus Eluting Stent (SES) among real world patients. DOCO, GCEP, TVF
68  2020 Comparison of 3-year clinical outcomes between Endeavor Resolute® and Resolute Integrity® zotarolimus-eluting stents in an Asian population. aHR, CI, I-ZES, MACEs, MI, PCI, R-ZES, TLR, TVR
69  2020 Comparison of 9-Month Angiographic Follow-Up and Long-Term Clinical Outcomes of Biodegradable Polymer Drug-Eluting Stents and Second-Generation Durable Polymer Drug-Eluting Stents in Patients Undergoing Single Coronary Artery Stenting. BP-DESs, DESs, DP, MACEs, MI, TVR
70  2020 Comparison of Clinical Characteristics of Stent Thrombosis Between the Right Coronary Artery and the Left Coronary Artery - A Subanalysis of the REAL-ST Registry. CI, CTO, DES, OR, RCA
71  2020 Comparison of Durable-Polymer- and Biodegradable-Polymer-Based Newer-Generation Drug-Eluting Stents in Patients with Acute Myocardial Infarction and Prediabetes After Successful Percutaneous Coronary Intervention. aHR, AMI, BES, BP, CI, DESs, DP, EES, MACEs, PCI, re-MI, TLR, TVR, ZES
72  2020 Comparison of First- and Second-Generation Drug-Eluting Stents in Patients with Acute Myocardial Infarction and Prediabetes Based on the Hemoglobin A1c Level. AMI, CI, DES, HR, PCI, POCOs, PSM, re-MI
73  2020 Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction. BVS, CI, EES, HR, PoCE, STEMI
74  2020 Comparison of the Major Clinical Outcomes for the Use of Endeavor® and Resolute Integrity® Zotarolimus-Eluting Stents During a Three-Year Follow-up. CI, E-ZES, HR, I-ZES, MACEs, MI, PCI, PSM
75  2020 Coronary Stent Thrombosis- Predictors and Prevention. DAPT, HR, OR
76  2020 COVID-19 pandemic and stent thrombosis in a post percutaneous coronary intervention patient-a case report highlighting the selection of P2Y12 inhibitor. CAG, COVID-19, LAD, PCI, PPE, RCA
77  2020 Culprit-only versus multivessel or complete versus incomplete revascularization in patients with non-ST-segment elevation myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention using newer-generation drug-eluting stents. aHR, C-PCI, CI, CR, DES, IR, M-PCI, MACEs, MVD, Non-TVR, NSTEMI
78  2020 Definite stent thrombosis among Malaysian population: predictors and insights of mechanisms from intracoronary imaging. HR, PCI
79  2020 Design of Self-Expanding Auxetic Stents Using Topology Optimization. BE, IRS, SE
80  2020 Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug eluting stent implantation: a network Meta-analysis. MI, PEP
81  2020 Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ACS, CI, DAPT, MACE, MI, PCI, RCTs, RR
82  2020 Efficacy and safety of an antithrombotic regimen for atrial fibrillation patients with acute coronary syndrome or those undergoing percutaneous coronary intervention: a meta-analysis. ACS, AF, CI, MI, PCI, RCTs, RR
83  2020 Efficacy and safety of bivalirudin vs heparin in patients with coronary heart disease undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials. CI, MACE, MI, RCT, RRs, STEMI, TVR
84  2020 Efficacy of Zotarolimus-Eluting Stents in Treating Diabetic Coronary Lesions: An Optical Coherence Tomography Study. DM, OCT, QCA, ZES
85  2020 Endpoint selection for noninferiority percutaneous coronary intervention trials: a methodological description. DAPT, MACE, NI
86  2020 Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent. DM, NSTE-ACS, TLF
87  2020 First clinical evidence characterizing safety and efficacy of the new CoCr Biolimus-A9 eluting stent: The Biomatrix Alpha™ registry. BES, ci-TVR, CoCr-BES, DAPT, MACE, MI
88  2020 Genotype-guided antiplatelet therapy compared with standard therapy for patients with acute coronary syndromes or undergoing percutaneous coronary intervention: A systematic review and meta-analysis. ACS, CI, HTPR, MACEs, MI, PCI, RCTs, RR, TVR
89  2020 Impact of Coronary Stent Architecture on Clinical Outcomes: Do Minor Changes in Stent Architecture Really Matter? MACE, MI, PF-SES, TLR
90  2020 Impact of direct stenting on clinical outcomes for small vessel coronary artery disease in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. CAD, CS, DS, MACE, MI, PPCI, STEMI, TLR, TVR
91  2020 Improved clinical outcome with biodegradable polymer drug-eluting stents compared to durable polymer drug-eluting stents for primary percutaneous coronary intervention. BP-DES, DP-DES, MACE, PPCI, STEMI
92  2020 Incidence and In-Hospital Outcomes of Patients Presenting With Stent Thrombosis (from the Japanese Nationwide Percutaneous Coronary Intervention Registry). ACS
93  2020 Incidence of Adverse Events at 3 Months Versus at 12Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations. DAPT, MI, TLR, TVR, ULM
94  2020 Incidence, Predictors and Clinical Outcomes of Stent Thrombosis Following Percutaneous Coronary Intervention in Contemporary Practice. PCI
95  2020 Independent Factors for In-Hospital Death Following Drug-Eluting Stent Thrombosis From the Japanese Adverse Event Report System. CHF, CI, DES, LMT, OR
96  2020 Meta-Analysis Comparing P2Y12 Inhibitors in Acute Coronary Syndrome. ACS, MACE, MI
97  2020 Meta-analysis of Duration of Continuous Dual Antiplatelet Therapy and Late Stent Thrombosis After Second-Generation Drug Stent Implantation. DAPT, DES, OR, PCI
98  2020 Midterm Clinical Impacts of Biodegradable Polymer Everolimus-Eluting Stents Compared with Durable Polymer Everolimus-Eluting Stents: A 3-Year Propensity-Matched Study. BP-EES, DP-EES, MI, TLF, TLR, TVR
99  2020 Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics. NGS
100  2020 NOAC-Based Sual Therapy Versus Warfarin-Based Triple Therapy After Percutaneous Coronary Intervention or Acute Coronary Syndrome in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis. ACS, CRNM, DT, ISTH, MACCE, NOAC, OR, PCI, RCTs, TT, VKA